About RapidAccess.ai
We're building the intelligence layer for pharmaceutical market access.
Our Vision
The pharmaceutical industry faces a critical challenge: navigating the complex landscape of drug approvals, reimbursement negotiations, and market access across multiple jurisdictions. Teams spend countless hours manually tracking regulatory decisions, HTA reviews, and pricing negotiations.
We believe there's a better way. RapidAccess.ai brings together fragmented data sources into a unified intelligence platform, powered by AI to surface insights that matter.
Our vision is to become the central nervous system for market access teams—giving them real-time visibility into the regulatory and reimbursement landscape so they can make faster, smarter decisions and ultimately get life-saving treatments to patients sooner.
Our Team
Nikita Goldovsky
Co-Founder
Roman Zilbershtein
Co-Founder
Ready to transform your market access strategy?
Join leading pharma and biotech companies using RapidAccess.ai to stay ahead.
Book a Demo